Andrea Lobo, PhD,  —

Andrea Lobo is a Science writer at BioNews. She holds a Biology degree and a PhD in Cell Biology/Neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. She was a postdoctoral and senior researcher at the Institute for Research and Innovation in Health in Porto, in drug addiction, studying neuronal plasticity induced by amphetamines. As a research scientist for 19 years, Andrea participated in academic projects in multiple research fields, from stroke, gene regulation, cancer, and rare diseases. She authored multiple research papers in peer-reviewed journals. She shifted towards a career in science writing and communication in 2022.

Articles by Andrea Lobo

Women more likely to develop sinonasal sarcoidosis: Review study

Sinonasal sarcoidosis, when the disease affects the nasal cavity and the surrounding air-filled cavities called the sinuses, mainly affects women and manifests as nasal obstruction, according to a review study. More than half of people with sinonasal sarcoidosis experience symptom lessening after treatment with medications and/or surgery. “Prompt…

Cardiac troponin T may be cardiac sarcoidosis prognosis biomarker

Blood levels of high-sensitivity cardiac troponin T (hs-cTnT), a marker of heart muscle damage, may serve as a prognostic biomarker for adverse events, including death and heart failure, in people with cardiac sarcoidosis, a study in Japan shows. Patients with combined elevated levels of both hs-cTnT and B-type natriuretic…

Small-airway biopsy may help with diagnosing sarcoidosis: Study

More than one-third of sarcoidosis patients have abnormalities in the small airways, or bronchioles, according to a study in Italy that looked at small-airway inspection and biopsy using ultrathin tubes. The researchers said this procedure could aid in diagnosing sarcoidosis. Small-airway biopsies yielded high rates of granuloma detection: 65.4%…

FSR expands scientific advisory board to improve research, care

The Foundation for Sarcoidosis Research (FSR), a nonprofit dedicated to finding new treatments and improving care for people with sarcoidosis, has nominated 14 new members to its scientific advisory board (SAB), with an aim of further enhancing research and patient care. The FSR SAB includes world-renowned researchers…

Walgreens, FSR unite in Alabama for Sarcoidosis Awareness Month

Walgreens and the Foundation for Sarcoidosis Research (FSR) have renewed their partnership to raise awareness about sarcoidosis and the importance of spring respiratory vaccines, as part of this April’s Sarcoidosis Awareness Month. Until the end of the month, all Alabama-based Walgreens stores will provide informational resources to…

Sarcoidosis tied to higher long-term venous thromboembolism risk

People with sarcoidosis are significantly more likely to develop venous thromboembolism (VTE), which occurs when a blood clot forms in a vein, over 10 years than the general population, a nationwide study in Denmark suggests. And while there are substantial differences in clinical characteristics between those who develop VTE…